NASDAQ
Claritas Pharmaceuticals, Inc. (CLAZF) has a fcf yield of -2315.39% as of Friday, May 29, 2026. This represents a 109.53% decrease compared to its 12-month average of -1105.02%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.